Ads
related to: ocrevus cost- Patient Support
Access Patient Resources
& Information For OCREVUS
- Patients Taking OCREVUS
Explore The Stories & Experiences
Of People Taking OCREVUS
- Infusion Experience
Learn More About The Infusion
Experience With OCREVUS
- OCREVUS Medication Guide
Download The Medication Guide
To Learn More About OCREVUS
- OCREVUS CONNECTS™
A Program Designed To Help Patients
With Financial & Infusion Support
- Safety & Side Effects
View Important Safety & Side Effect
Information On The Official Site
- Patient Support
Search results
Biogen Inc. (BIIB) Down 4.8% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoIt has been about a month since the last earnings report for Biogen Inc. (BIIB). Shares have lost...
Biogen (BIIB) Beats on Q2 Earnings & Sales, Ups 2022 Guidance
Zacks via Yahoo Finance· 2 years agoBiogen BIIB reported second-quarter 2022 earnings per share (EPS) of $5.25, which significantly beat...
What Is the First Line of Treatment for Multiple Sclerosis?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Lindsay Cook, PharmD In multiple sclerosis (MS), the immune system attacks the...
Biogen (BIIB) Q4 Earnings & Sales Miss Estimates, Stock Falls
Zacks via Yahoo Finance· 4 months agoBiogen BIIB reported fourth-quarter 2023 adjusted earnings per share (EPS) of $2.95, which missed...
Novartis lifts 2023 earnings forecast for third time
Reuters via Yahoo News· 7 months agoBy Ludwig Burger FRANKFURT (Reuters) -Switzerland's Novartis on Tuesday raised its full-year earnings forecast for the third time, citing cost cuts and...
Biogen Raises Annual Guidance Despite Q3 Earning Impacted By Biosimilar Competition
Benzinga via Yahoo Finance· 2 years agoBiogen Inc (NASDAQ: BIIB) posted Q3 sales of $2.51 billion, beating the consensus of $2.47 billion,...
Earnings Beat, Increased FY22 Outlook, Rising Biosimilar Competition: Biogen's Q2 Highlights
Benzinga via Yahoo Finance· 2 years agoBiogen Inc (NASDAQ: BIIB) has posted Q2 sales of $2.59 billion, beating the consensus of $2.48...
Q2 Earnings Scorecard and Analyst Reports for Roche, Adobe & McDonald's
Zacks via Yahoo Finance· 2 years agoTuesday, August 9, 2022 The Zacks Research Daily presents the best research output of our analyst...
The Zacks Analyst Blog Highlights Chevron, Roche Holding, General Electric, Centene and Carrier...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – December 14, 2022 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights Alphabet, Roche Holding, Honeywell International, IBM and The...
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 29, 2023 – Zacks.com announces the list of stocks...
Ads
related to: ocrevus cost